Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.60 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.60 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.60 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.60 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1408747 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL1408996 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL27907118 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL34673 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL1409030 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL25212094 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL1408786 | 1.00 | ALDH1A1 (0.61) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| Ammonia Solution, Strong SCHEMBL3318542 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| Ammonia Solution, Strong SCHEMBL389310 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRPRMT3CARM1PRMT6 | |
| SCHEMBL27841337 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRPRMT3CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111440311-B | Process method for producing polyphenyl ether | 李同军 | 2023-03-14 | — | — | CN | claimed |
| CN-111440311-A | Technological method for producing polyphenyl ether | 李同军 | 2020-07-24 | — | — | CN | claimed |
| CN-103974993-B | Liquid accelerator compositionss for sclerosing agent | 蓝立方知识产权有限责任公司 | 2017-03-08 | — | — | CN | claimed |
| WO-2016176568-A1 | HARDENER COMPOSITION | BLUE CUBE IP LLC (US) | 2016-11-03 | — | — | WO | claimed |
| EP-0614664-B2 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-01-08 | — | — | EP | claimed |
| EP-0614664-B1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-09-16 | — | — | EP | claimed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | claimed |
| EP-2295438-B2 | PROCESS FOR PRODUCING HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND, AND CATALYST COMPOSITION FOR THE PRODUCTION OF POLYURETHANE RESIN USING THE HYDROXYALKYLTRIETHYLENEDIAMINE COMPOUND | TOSOH CORP (JP) | 2025-03-26 | — | — | EP | disclosed |
| CN-119488484-A | Liposome preparation and preparation method thereof | 纳科药业科技(深圳)有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-20240101327-A1 | ELASTOMER CONTAINING MULTILAYER FILM AND METHOD OF MANUFACTURE | CRYOVAC, LLC | 2024-03-28 | — | — | US | disclosed |
| EP-4328309-A2 | LIPID COMPOSITION | FUJIFILM Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| US-20230357545-A1 | METHOD FOR MAKING A COMPATIBILIZED BLEND FROM A BLEND OF POLYMERIC MATERIAL | CRYOVAC, LLC | 2023-11-09 | — | — | US | disclosed |
| US-20230320995-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | CAPSTAN THERAPEUTICS, INC. (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2001083318-A2 | OXYGEN SCAVENGING HIGH BARRIER POLYAMIDE COMPOSITIONS FOR PACKAGING APPLICATIONS | HONEYWELL INTERNATIONAL INC. (US) | 2001-11-08 | — | — | WO | disclosed |
| WO-2000077097-A1 | TRANSPARENT POLYAMIDE COMPOSITIONS | ALLIEDSIGNAL INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| US-5889009-A | ADMINISTERING 1,7-DISUBSTITUTED-4-OX-3-(QUINOLINECARBOXYLIC ACID OR NAPHTHYRIDINECARBOXYLIC ACID) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| EP-0614664-B1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-09-16 | — | — | EP | disclosed |
| US-5703081-A | CELL ADHESION INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-30 | — | — | US | disclosed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | disclosed |
| EP-0614664-A1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230320995-A1 | IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES | PLTP, LNPEP, PLIN3 | ALDH1A1 4315/4885TSHR 894/4885PRMT3 2761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.